AVIGEN INC \DE
S-1MEF, 1996-05-22
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CIT GROUP SECURITIZATION CORP II, 8-K, 1996-05-22
Next: AVIGEN INC DE, 424B4, 1996-05-22



<PAGE>   1
 
      AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 22, 1996
 
                                                      REGISTRATION NO. 333-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                            ------------------------
 
                                    FORM S-1
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                            ------------------------
 
                                  AVIGEN, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
<TABLE>
<S>                                   <C>                                   <C>
               DELAWARE                                8731                               13-3647113
       (STATE OF INCORPORATION)            (PRIMARY STANDARD INDUSTRIAL        (I.R.S. EMPLOYER IDENTIFICATION
                                           CLASSIFICATION CODE NUMBER)                     NUMBER)
</TABLE>
 
                            ------------------------
 
                         1201 HARBOR BAY PARKWAY, #1000
                               ALAMEDA, CA 94502
                                 (510) 748-7150
         (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING
            AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
 
                            ------------------------
 
                              JOHN MONAHAN, PH.D.
                     PRESIDENT AND CHIEF EXECUTIVE OFFICER
                                  AVIGEN, INC.
                        1201 HARBOR BAY PARKWAY, # 1000
                               ALAMEDA, CA 94502
                                 (510) 748-7150
 (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER; INCLUDING AREA CODE,
                             OF AGENT FOR SERVICE)
 
                            ------------------------
 
                                   COPIES TO:
 
<TABLE>
<S>                                                     <C>
                ALAN C. MENDELSON, ESQ.                                 E. MICHAEL GREANEY, ESQ.
                ROBERT J. BRIGHAM, ESQ.                               GIBSON, DUNN & CRUTCHER LLP
                 COOLEY GODWARD CASTRO                                        4 PARK PLAZA
                   HUDDLESON & TATUM                                        IRVINE, CA 92714
                 FIVE PALO ALTO SQUARE                                       (714) 451-3800
                  3000 EL CAMINO REAL
                PALO ALTO, CA 94306-2155
                     (415) 843-5000
</TABLE>
 
                            ------------------------
 
        APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
  As soon as possible after the effective date of this Registration Statement
 
                            ------------------------
 
     If this Form is to be filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please check the box
and list the registration statement number of the earlier effective registration
statement for the same offering.  /X/  333-3220
                            ------------------------
 
                        CALCULATION OF REGISTRATION FEE
 
<TABLE>
<S>                                      <C>              <C>              <C>              <C>
- ------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------
                                                              PROPOSED         PROPOSED
                                                              MAXIMUM          MAXIMUM
                                                              OFFERING        AGGREGATE        AMOUNT OF
TITLE OF SECURITIES                        AMOUNT TO BE      PRICE PER         OFFERING       REGISTRATION
TO BE REGISTERED                          REGISTERED(1)        SHARE            PRICE            FEE(2)
- ------------------------------------------------------------------------------------------------------------
Common Stock, par value $.001 per
  share.................................  230,000 shares       $8.00          $1,840,000        $634.48
- ------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------
</TABLE>
 
     This Registration Statement shall hereafter become effective in accordance
with Section 8(a) of the Securities Act of 1933 on such date as the Commission,
acting pursuant to said Section 8(a), may determine.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>   2
 
                                EXPLANATORY NOTE
 
     This registration statement is being filed pursuant to Rule 462(b) and
General Instruction IV of Form S-1. Incorporated by reference herein is, in its
entirety, the Registration Statement on Form S-1 (File No. 333-3220) of Avigen,
Inc., which was declared effective by the Securities and Exchange Commission on
May 21, 1996.
<PAGE>   3
 
                                   SIGNATURES
 
     Pursuant to the requirements of the Securities Act of 1933, Avigen, Inc.
has duly caused this Registration Statement to be signed on its behalf, by the
undersigned, thereunto duly authorized, in the City of Alameda, County of
Alameda, State of California, on May 21, 1996.
 
                                          AVIGEN, INC.
 
                                          By:    /s/  JOHN MONAHAN, PH.D.
                                                     John Monahan, Ph.D.
                                             President, Chief Executive Officer
                                                         and Director
 
     PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, THIS
REGISTRATION STATEMENT HAS BEEN SIGNED BY THE FOLLOWING PERSONS IN THE
CAPACITIES AND ON THE DATES INDICATED.
 
<TABLE>
<CAPTION>
                  SIGNATURE                                 TITLE                     DATE
- ---------------------------------------------  --------------------------------  ---------------
<C>                                            <S>                               <C>
          /s/  JOHN MONAHAN, PH.D.             President, Chief Executive           May 21, 1996
- ---------------------------------------------  Officer and Director (Principal
             John Monahan, Ph.D.               Executive Officer)
                GLENN BAUER*                   Controller (Principal Accounting     May 21, 1996
- ---------------------------------------------  Officer)
                 Glenn Bauer
         PHILIP J. WHITCOME, PH.D.*            Chairman of the Board and acting     May 21, 1996
- ---------------------------------------------  Chief Financial Officer
          Philip J. Whitcome, Ph.D.            (Principal Financial Officer)
            ZOLA HOROVITZ, PH.D.*              Director                             May 21, 1996
- ---------------------------------------------
            Zola Horovitz, Ph.D.
         YUICHI IWAKI, M.D., PH.D.*            Director                             May 21, 1996
- ---------------------------------------------
          Yuichi Iwaki, M.D., Ph.D.
              RICHARD T. PRATT*                Director                             May 21, 1996
- ---------------------------------------------
              Richard T. Pratt
        JOHN K.A. PRENDERGAST, PH.D.*          Director                             May 21, 1996
- ---------------------------------------------
        John K.A. Prendergast, Ph.D.
          LINDSAY A. ROSENWALD, M.D.*          Director                             May 21, 1996
- ---------------------------------------------
         Lindsay A. Rosenwald, M.D.
             LEONARD P. SHAYKIN*               Director                             May 21, 1996
- ---------------------------------------------
             Leonard P. Shaykin

*By:    /s/  JOHN MONAHAN
- ---------------------------------------------
             John Monahan, Ph.D.
              Attorney-in-Fact
</TABLE>
<PAGE>   4
 
                                 EXHIBIT INDEX
 
<TABLE>
<CAPTION>
                                                                                     SEQUENTIALLY
EXHIBIT                                                                                NUMBERED
NUMBER                            DESCRIPTION OF DOCUMENT                                PAGE
- ------   --------------------------------------------------------------------------  ------------
<C>      <S>                                                                         <C>
  5.1    Opinion of Cooley Godward Castro Huddleson & Tatum........................
 23.1    Consent of Ernst & Young LLP, Independent Auditors........................
 23.2    Consent of Cooley Godward Castro Huddleson & Tatum (included in Exhibit
         5.1)......................................................................
</TABLE>

<PAGE>   1
                                                                     Exhibit 5.1

              [COOLEY GODWARD CASTRO HUDDLESON & TATUM LETTERHEAD]


May 21, 1996



Avigen, Inc.
1201 Harbor Bay Parkway, Suite 1000
Alameda, California 94502


Ladies and Gentlemen:

You have requested our opinion with respect to certain matters in connection
with the filing by Avigen, Inc. (the "Company") of a Registration Statement on
Form S-1 (the "Registration Statement"), pursuant to Rule 462(b), with the
Securities and Exchange Commission (the "Commission") covering an offering by
the Company of up to an additional 230,000 shares of the Company's Common Stock,
as described in the Registration Statement (the "Common Stock"). The
Registration Statement relates to the same offering as described in Registration
Statement No. 333-3220.

In connection with this opinion, we have examined and relied upon the
Registration Statement, the Company's Restated Certificate of Incorporation, as
amended and Bylaws and the originals or copies certified to our satisfaction, of
such records, documents, certificates, memoranda and other instruments as in our
judgment are necessary or appropriate to enable us to render the opinion
expressed below.

On the basis of the foregoing, and in reliance thereon, we are of the opinion
that the Common Stock, when sold in accordance with the Registration Statement,
will be validly issued, fully paid and nonassessable.

We consent to the reference to our firm under the caption "Legal Matters" in the
Prospectus included in the Registration Statement and to the filing of this
opinion as an exhibit to the Registration Statement.


Very truly yours,

COOLEY GODWARD CASTRO
  HUDDLESON & TATUM


By /s/ Andrei M. Manoliu
   ---------------------------------
       Andrei M. Manoliu


<PAGE>   1
 
                                                                    EXHIBIT 23.1
 
               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
 
     We consent to the reference to our firm under the captions "Selected
Financial Data" and "Experts" and to the use of our report dated September 8,
1995 (except Note 10 as to which the date is May 7, 1996) in this Registration
Statement filed pursuant to Rule 462(b) of Avigen, Inc.
 
                                          ERNST & YOUNG LLP
 
Walnut Creek, California
May 21, 1996


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission